This article provides an update on the 2015 Canadian Hypertension Education Program (CHEP) guidelines specifically tailored for pharmacists.
Empowers pharmacists to implement electronic BP monitoring and out-of-office confirmation; extends CHEP guidelines into community practice.
Since 1999, the Canadian Hypertension Education Program (CHEP) has released annual recommendations on the management of hypertension. Although significant improvements in hypertension treatment and control have been made in Canada, approximately one-third of Canadians continue to have uncontrolled blood pressure.1 In 2011, we published a set of guidelines specific to pharmacists based on the CHEP recommendations.2 Since that publication, new research has been conducted that has prompted changes in the 2012 and 2013 versions of the guidelines. In this article, we will provide an update for pharmacists on these changes and their underlying evidence, as relevant to pharmacy practice.
No takes yet. Share an insight, caveat, or question.
Houle et al. (2015) conducted a review in Hypertension. 2015 CHEP Guidelines was evaluated. The 2015 Canadian Hypertension Education Program guidelines recommend electronic blood pressure monitors, out-of-office measurement to confirm diagnosis, and smoking cessation for hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: